Discover
KRRO
Korro Bio, Inc.
10.16
2 x 7.64
2 x 13.08
bid
ask
-
0.42
3.97%
2 @ 04:56 PM
10.01 -0.15 (1.48%)
| Ytd | 26.84% | |
| 1y | -78.26% |
10.13
day range
10.78
5.28
52 week range
51.36
| Open | 10.60 | Prev Close | 10.58 | Low | 10.13 | High | 10.78 | Mkt Cap | 149.61M |
| Vol | 133.51K | Avg Vol | 148.86K | EPS | -9.50 | P/E | N/A | Forward P/E | -4.29 |
| Beta | 3.13 | Short Ratio | 2.64 | Inst. Own | 91.36% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 11.91 | 200-d Avg | 11.74 | 1yr Est | 137.76 |
| Income Statement | |||
| Operating Expenses | 20.11M | ||
| Research and Development Expense | 13.59M | ||
| Selling, General and Administrative Expense | 6.52M | ||
| Operating Income | -20.11M | ||
| Income Tax Expense | 108.00K | ||
| Net Income | -18.92M | ||
| Net Income Common Stock | -18.92M | ||
| Net Income Common Stock (USD) | -18.92M | ||
| Consolidated Income | -18.92M | ||
| Earnings per Basic Share | -1.07 | ||
| Earnings per Basic Share (USD) | -1.07 | ||
| Earnings per Diluted Share | -1.07 | ||
| Earning Before Interest & Taxes (EBIT) | -18.81M | ||
| Earning Before Interest & Taxes (USD) | -18.81M | ||
| Weighted Average Shares | 17.62M | ||
| Weighted Average Shares Diluted | 17.62M | ||
| Balance Sheet | |||
| Cash and Equivalents | 24.91M | ||
| Cash and Equivalents (USD) | 24.91M | ||
| Investments | 115.43M | ||
| Investments Current | 90.13M | ||
| Investments Non-Current | 25.29M | ||
| Current Assets | 120.63M | ||
| Property, Plant & Equipment Net | 15.05M | ||
| Total Assets | 163.45M | ||
| Debt Current | 2.94M | ||
| Total Debt | 42.21M | ||
| Current Liabilities | 12.63M | ||
| Debt Non-Current | 39.28M | ||
| Total Liabilities | 60.22M | ||
| Accumulated Retained Earnings (Deficit) | -422.39M | ||
| Accumulated Other Comprehensive Income | -189.00K | ||
| Shareholders Equity | 103.23M | ||
| Shareholders Equity (USD) | 103.23M | ||
| Assets Non-Current | 42.82M | ||
| Total Debt (USD) | 42.21M | ||
| Deferred Revenue | 7.84M | ||
| Liabilities Non-Current | 47.59M | ||
| Trade and Non-Trade Payables | 3.60M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 607.00K | ||
| Net Cash Flow from Financing | -2.92M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -37.79M | ||
| Capital Expenditure | -37.00K | ||
| Issuance (Purchase) of Equity Shares | -2.92M | ||
| Net Cash Flow from Investing | -17.90M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -17.86M | ||
| Net Cash Flow from Operations | -16.99M | ||
| Effect of Exchange Rate Changes on Cash | 22.00K | ||
| Share Based Compensation | 2.70M | ||